CLINICAL_TRIALS
trial_result
· 2020-11-12
Clinical Trial Update: Gemcabene for the Treatment of Pediatric NAFLD [Phase 2]
Summary
Phase 2 trial of gemcabene for pediatric non-alcoholic fatty liver disease was terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Emory University | Conditions: Non-Alcoholic Fatty Liver Disease | Phase 2 | Status: TERMINATED | Results posted: 2020-11-12